Taiwan FDA registration 1c6e5191336a83e044de4ec8ec778ff2
“Abbott” XIENCE Alpine Everolimus Eluting Coronary Stent System
TW: “亞培”賽恩斯高艾諾莉茉斯冠狀動脈塗藥支架系統
Taiwan·Risk Class 3·MD·ABBOTT VASCULAR·Registered Mar 31, 2016 – Mar 31, 2026ExpiredRegistration details
- Analysis ID
- 1c6e5191336a83e044de4ec8ec778ff2
- License Form
- Ministry of Health Medical Device Import No. 028278
- Customs Code
- DHA05602827801
Company information
- Manufacturer
- ABBOTT VASCULAR
- Manufacturer Country
- Ireland
- Authorized Representative
- Abbott Medical Taiwan Co.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- E Cardiovascular devices
- Product Type (Level 2)
- E0001 Cardiovascular stents
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Mar 31, 2016
- Expiry Date
- Mar 31, 2026
About this record
Access comprehensive regulatory information for “Abbott” XIENCE Alpine Everolimus Eluting Coronary Stent System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 1c6e5191336a83e044de4ec8ec778ff2 and manufactured by ABBOTT VASCULAR. The authorized representative in Taiwan is Abbott Medical Taiwan Co..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices